Examining retinal blood vessels in patients with common internal diseases using advanced imaging
Retinal Vascular Manifestations in Patients With Common Internal Diseases on Optical Coherence Tomography Angiography
This study is trying to see how conditions like high blood pressure, diabetes, and high cholesterol affect the blood vessels in the eyes over five years using advanced imaging technology.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Beijing Tongren Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT05644548 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate retinal vascular changes in patients with hypertension, diabetes mellitus, and dyslipidemia using optical coherence tomography angiography (OCTA). The study will collect comprehensive patient data, including demographics, comorbidities, medications, and various laboratory tests over a follow-up period of five years. By utilizing OCTA, the researchers hope to quantify vascular changes in a noninvasive manner, providing valuable insights into the relationship between these common internal diseases and retinal health.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with hypertension, diabetes mellitus, or dyslipidemia who are willing to participate.
Not a fit: Patients with malignant tumors, autoimmune diseases, or immunodeficiency diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of retinal vascular changes associated with common internal diseases, potentially leading to improved patient management.
How similar studies have performed: Previous studies have utilized color fundus photography for similar assessments, but this study's use of OCTA represents a novel approach with the potential for more precise quantification.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with hypertension * Or patients with diabetes * Or patients with dyslipidemia * Agree to participate in this study Exclusion Criteria: * Patients with malignant tumors * Patients with autoimmune diseases * Patients with immunodeficiency disease * Disagree to participate in this study
Where this trial is running
Beijing, Beijing Municipality
- Beijing Tongren Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Yu He, MD
- Email: bluelight323@126.com
- Phone: +861058268320
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.